Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × nilotinib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Leukemia, Myeloid, Chronic-Phase 6 Neoplasm Metastasis 4 Philadelphia Chromosome 2 Neoplasms 2 Neoplasm, Residual 2 Myeloproliferative Disorders 2 Leukemia 2 Synovitis, Pigmented Villonodular 1 Sarcoma 1 Ovarian Neoplasms 1 Leukemia, Myeloid 1 Hematologic Diseases 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Brentuximab Vedotin 5 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 romidepsin 3 pembrolizumab 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡